Attached files
| file | filename |
|---|---|
| EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - CNS Pharmaceuticals, Inc. | cns_ex2301.htm |
| 10-K/A - AMENDED ANNUAL REPORT - CNS Pharmaceuticals, Inc. | cns_10ka1-123120.htm |
| EX-31.4 - CERTIFICATION BY OFFICER - CNS Pharmaceuticals, Inc. | cns_ex3104.htm |
EXHIBIT 31.3
CERTIFICATION BY OFFICER
I, John Climaco, certify that:
| 1. | I have reviewed this Form 10-K for the year ended December 31, 2020 of CNS Pharmaceuticals, Inc.; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| Date: February 16, 2021 | By: | /s/ John Climaco |
| John Climaco | ||
| Chief Executive Officer and President |